| Literature DB >> 30711529 |
Ke Nie1, Hania Al-Hallaq2, X Allen Li3, Stanley H Benedict4, Jason W Sohn5, Jean M Moran6, Yong Fan7, Mi Huang8, Michael V Knopp9, Jeff M Michalski10, James Monroe11, Ceferino Obcemea12, Christina I Tsien10, Timothy Solberg13, Jackie Wu14, Ping Xia15, Ying Xiao8, Issam El Naqa2.
Abstract
Radiomics is a fast-growing research area based on converting standard-of-care imaging into quantitative minable data and building subsequent predictive models to personalize treatment. Radiomics has been proposed as a study objective in clinical trial concepts and a potential biomarker for stratifying patients across interventional treatment arms. In recognizing the growing importance of radiomics in oncology, a group of medical physicists and clinicians from NRG Oncology reviewed the current status of the field and identified critical issues, providing a general assessment and early recommendations for incorporation in oncology studies.Entities:
Mesh：
Year: 2019 PMID： 30711529 PMCID： PMC6499656 DOI： 10.1016/j.ijrobp.2019.01.087
Source DB: PubMed Journal: Int J Radiat Oncol Biol Phys ISSN： 0360-3016 Impact factor: 7.038